Edition:
United Kingdom

Aptose Biosciences Inc (APTO.OQ)

APTO.OQ on NASDAQ Stock Exchange Capital Market

2.71USD
19 Sep 2018
Change (% chg)

-- (--)
Prev Close
$2.71
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
51,481
52-wk High
$4.55
52-wk Low
$1.30

Chart for

About

Aptose Biosciences Inc. (Aptose) is a clinical-stage biotechnology company. The Company is engaged in the development of anticancer drugs that target specific epigenetic processes and signal transduction abnormalities that underlie a particular life-threatening malignancy. Its product pipeline includes cancer drug candidates... (more)

Overall

Beta: 2.10
Market Cap(Mil.): $33.86
Shares Outstanding(Mil.): 24.17
Dividend: --
Yield (%): --

Financials

  APTO.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -0.80 -- --
ROI: -123.77 1.78 14.61
ROE: -123.77 3.27 16.33

BRIEF-Aptose Biosciences Says Exercises Early Option For Cg-806 License From Crystalgenomics

* APTOSE BIOSCIENCES INC - EXERCISES EARLY OPTION FOR CG-806 LICENSE FROM CRYSTALGENOMICS

07 May 2018

BRIEF-Aptose Biosciences Establishes New At-The-Market Facility

* APTOSE BIOSCIENCES INC SAYS ENTERED INTO AN "AT-THE-MARKET" SALES AGREEMENT WITH CANTOR FITZGERALD & CO

28 Mar 2018

BRIEF-Aptose Reports Qtrly Loss Of $0.12‍​ Per Share

* APTOSE REPORTS RESULTS FOR THE FOURTH QUARTER AND YEAR ENDED DECEMBER 31, 2017

27 Mar 2018

Earnings vs. Estimates